Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer.

Familial cancer - 1 Dec 2013

Alanee Shaheen, Shah Sohela, Vijai Joseph, Schrader Kasmintan, Hamilton Robert, Rau-Murthy Rohini, Sarrel Kara, Manschreck Christopher, Eastham James, Offit Kenneth

Abstract excerpt

We performed a retrospective analysis of germline DNA samples from Ashkenazi Jewish men and a comparison group of non-Ashkenazi men treated for prostate cancer at our institution to determine the prevalence of HOXB13 G84E mutation in prostate cancer patients of Ashkenazi Jewish heritage, an ethnic group common to the New York City area. Patients were genotyped for G84E using a TaqMan assay (Applied Biosystems)....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Follow-Up Studies
Share to Homeodomain Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Grading

Share to Neoplasm Metastasis

Share to Neoplasm Staging

Share to New York

Share to Prostatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 23475555
DOI: 10.1007/s10689-013-9618-y
PMCID: PMC5073797

Genes

HOXB13

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer.PMID 23475555Read ↗

Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.Semantic proximity Read ↗

Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancerSemantic proximity Read ↗

Association between germline HOXB13 G84E mutation and risk of prostate cancer.Semantic proximity Read ↗

Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.Semantic proximity Read ↗

The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies.Semantic proximity Read ↗

Identifying Ashkenazi Jewish BRCA1/2 founder variants in individuals who do not self-report Jewish ancestry.Semantic proximity Read ↗

Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.Semantic proximity Read ↗

Identifying Ashkenazi Jewish <i>BRCA1/2</i> founder variants in individuals who do not self-report Jewish ancestrySemantic proximity Read ↗

Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy.Semantic proximity Read ↗

The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews.Semantic proximity Read ↗

Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry.Semantic proximity Read ↗

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.